CYTOKINETICS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cytokinetics Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Cytokinetics Inc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $77.2M, a 4.47% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $77.2M -$3.62M -4.47% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $78.2M -$3.63M -4.44% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $79M -$3.75M -4.53% Dec 31, 2023 10-Q 2024-08-09
Q3 2023 $79.9M +$4.85M +6.46% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $80.9M +$8.71M +12.1% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $81.8M +$9.16M +12.6% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $82.7M +$9.6M +13.1% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $75.1M -$5.65M -7% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $72.2M -$10.8M -13.1% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $72.6M -$7.04M -8.84% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $73.1M +$70.2M +2401% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $80.7M Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $83M Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $79.7M Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $2.92M Dec 31, 2020 10-K 2022-02-25
Q4 2018 $9.6M Jan 1, 2019 10-K 2021-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.